Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/18/2012 | US8268303 Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
09/18/2012 | US8268302 Cultures, products and methods using umbilical cord matrix cells |
09/18/2012 | CA2647086C Identification of a jak2 mutation in polycythemia vera |
09/18/2012 | CA2516157C Expression vectors comprising the mcmv ie2 promoter |
09/18/2012 | CA2515552C Method and apparatus of cultivating multipotent stem cell |
09/18/2012 | CA2474146C A method for evolving a cell having desired phenotype and evolved cells |
09/18/2012 | CA2462610C Specific binding agents of human angiopoietin-2 |
09/18/2012 | CA2454807C Cultured cell construct which contains spheroids of cultured animal cells and the use thereof |
09/18/2012 | CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same |
09/18/2012 | CA2445746C Chimeric immunoreceptor useful in treating human cancers |
09/18/2012 | CA2424602C Antibody composition-producing cell |
09/18/2012 | CA2405345C Joint repair using mesenchymal stem cells |
09/18/2012 | CA2383136C Obg3 globular head and uses thereof for decreasing body mass |
09/18/2012 | CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia |
09/18/2012 | CA2296750C Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
09/18/2012 | CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
09/18/2012 | CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
09/18/2012 | CA2252972C Serum-free production of recombinant proteins and adenoviral vectors |
09/18/2012 | CA2221293C Helper virus-free aav production |
09/13/2012 | WO2012122519A2 Ligands to the membrane protein caveolin |
09/13/2012 | WO2012122298A2 Compositions and methods for identifying virulence factors and anti-fungal agents |
09/13/2012 | WO2012122239A1 MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER |
09/13/2012 | WO2012122019A1 Barley cultivar moravian 115 |
09/13/2012 | WO2012122015A2 Selective inhibitors of tumor-initiating cells |
09/13/2012 | WO2012121807A1 Device and method to activate platelets |
09/13/2012 | WO2012121778A1 Treatment of endometriosis by intravaginal administration of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent |
09/13/2012 | WO2012121577A2 Composition for strengthening tissue regenerative power of stem cell having pten |
09/13/2012 | WO2012121521A2 Method of oocyte cryopreservation using antifreeze protein |
09/13/2012 | WO2012121485A2 Method for inducing in vivo migration of stem cell |
09/13/2012 | WO2012121463A1 Bone-graft-substance production device |
09/13/2012 | WO2012121451A1 Method for inducing in vivo migration of stem cell |
09/13/2012 | WO2012121448A1 Bone graft substitute production method |
09/13/2012 | WO2012121428A1 Fibroblast growth composition comprising a dipeptide as an active ingredient, and a product comprising the composition |
09/13/2012 | WO2012121093A1 Complex disease resistant monocot having optimized agronomic characteristics |
09/13/2012 | WO2012121071A1 ADENOVIRUS VECTOR IN WHICH VA-RNAs ARE NOT EXPRESSED |
09/13/2012 | WO2012103098A3 Compositions and methods for treating hematological cytopenias |
09/13/2012 | WO2012072268A3 Anti cd4 antibodies to prevent in particular graft -versus - host - disease (gvhd) |
09/13/2012 | US20120233726 Novel bacillus thuringiensis gene with lepidopteran activity |
09/13/2012 | US20120233723 Herbicide-resistant rice plants, polynucleotides encoding herbicide resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
09/13/2012 | US20120233721 Cotton Cultivar L-1851 |
09/13/2012 | US20120233720 Tomato hybrid ex15567631 and parent lines thereof |
09/13/2012 | US20120233719 Tomato hybrid ex15567101 and parent lines thereof |
09/13/2012 | US20120233717 Method for preparing a transgenic animal of simultaneous multiple-gene expression |
09/13/2012 | US20120233716 Novel fatty acid elongase and uses thereof |
09/13/2012 | US20120233713 Methods and systems for inducible ablation of neural cells |
09/13/2012 | US20120232588 Surgical thread comprising cells and method of manufacturing the thread |
09/13/2012 | US20120232131 Gene expression and pain |
09/13/2012 | US20120232124 Compositions and methods for prognosis and treatment of prostate cancer |
09/13/2012 | US20120232062 Azaindazoles to treat flaviviridae virus infection |
09/13/2012 | US20120232032 Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material |
09/13/2012 | US20120232028 Bicyclic Compound, Production and Use Thereof |
09/13/2012 | US20120232018 Polycarbonates for delivery of drugs and methods of preparation thereof |
09/13/2012 | US20120232014 Antithrombotic compounds |
09/13/2012 | US20120232012 Compositions having antiangiogenic activity and uses thereof |
09/13/2012 | US20120232005 Lipoprotein complexes and manufacturing and uses thereof |
09/13/2012 | US20120232000 Methods and compositions for promoting regeneration by increasing intracellular sodium concentration |
09/13/2012 | US20120231997 Recombinant human cc10 protein for treatment of influenza |
09/13/2012 | US20120231544 Cell growth apparatus and use of aerogels for directed cell growth |
09/13/2012 | US20120231543 Novel opioid antagonists |
09/13/2012 | US20120231542 Biologically Active Human Umbilical Cord Blood Cell Extract Compounds and Methods |
09/13/2012 | US20120231541 FLUORESCENCE POLARIZATION hERG ASSAY |
09/13/2012 | US20120231540 Non-Simian Cells for Growth of Porcine Reproductive and Respiratory Syndrome (PRRS) Virus |
09/13/2012 | US20120231539 Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR) |
09/13/2012 | US20120231538 Lipophilic dye-based fret assays for clostridial toxin activity |
09/13/2012 | US20120231523 Recombinant factor x with no glycosylation and method for preparing the same |
09/13/2012 | US20120231520 Novel fusion proteins and method of expression thereof |
09/13/2012 | US20120231500 Cells For Transient Expression And Uses Thereof |
09/13/2012 | US20120231490 Method Of Differentiation From Stem Cells To Hepatocytes |
09/13/2012 | US20120231487 Method for preparing an invasive test of an egg and for determining a gender of an embryo in an egg |
09/13/2012 | US20120231451 Induction of Germ Cells from Pluripotent Cells |
09/13/2012 | US20120231450 Novel pacemaker cell |
09/13/2012 | US20120231449 Products and methods for enhanced transgene expression and processing |
09/13/2012 | US20120231448 Low cell toxicity antibiotic hygromycin b |
09/13/2012 | US20120231446 Method for selectively enriching and isolating microbial and optionally additional viral nucleic acids |
09/13/2012 | US20120231091 Method for Inducing Differentiation of Dental Pulp Cells Into Odontoblasts |
09/13/2012 | US20120231065 Methods of treating neurological conditions with hematopoeitic growth factors |
09/13/2012 | US20120231030 Multi-epitopic vaccine |
09/13/2012 | US20120231023 Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells |
09/13/2012 | US20120231021 Antibodies specifically binding to the epidermal growth factor receptor |
09/13/2012 | US20120231014 Neural Regeneration |
09/13/2012 | US20120231013 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
09/13/2012 | US20120231011 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody |
09/13/2012 | US20120231007 Modulators of cell cycle progression |
09/13/2012 | US20120231006 Anti-orai1 antigen binding proteins and uses thereof |
09/13/2012 | US20120231005 Ax1 and ax189 psck9 antagonists and variants |
09/13/2012 | US20120230999 Bispecific nanobodies as a therapeutic for alzheimer's disease |
09/13/2012 | US20120230998 Ip-10 antibodies and their uses |
09/13/2012 | US20120230992 Vegf-related protein |
09/13/2012 | US20120230991 Methods and compounds for enhancing anti-cancer therapy |
09/13/2012 | US20120230990 Humanized antibodies against human il-22ra |
09/13/2012 | US20120230985 Humanized anti-factor d antibodies and uses thereof |
09/13/2012 | US20120230980 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION |
09/13/2012 | US20120230979 NOGO Receptor Binding Protein |
09/13/2012 | US20120230971 Chromosomal modification involving the induction of double-stranded dna cleavage and homologous recombination at the cleavage site |
09/13/2012 | US20120230969 Method and product for blood treatment and purification |
09/13/2012 | US20120230967 Device and method to activate platelets |
09/13/2012 | US20120230966 Tissue transplant compositions and methods for use |
09/13/2012 | US20120230963 Methods and Compositions for Expanding, Identifying, Characterizing and Enhancing Potency of Mammalian-Derived Glial Restricted Progenitor Cells |
09/13/2012 | US20120230962 Gp100-specific t cell receptors and related materials and methods of use |
09/13/2012 | US20120230961 Mesenchymal stem cell and the method of use thereof |